Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|4|536-544

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.4, 2014-02, pp. : 536-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging targets for the treatment of scleroderma

By Leask Andrew  

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 173-179

Informa Healthcare

Access to resources Recommend Favorite

Phospholipid-mediated signaling systems as novel targets for treatment of heart disease

By Tappia Paramjit S.  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 1, 2007-01 ,pp. : 25-41

NRC Research Press

Access to resources Recommend Favorite

Epigenomic targets for the treatment of respiratory disease

By Bowman Rayleen V   Wright Casey M   Davidson Morgan R   Savarimuthu Francis Santiyagu M   Yang Ian A   Fong Kwun M  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 6, 2009-06 ,pp. : 625-640

Informa Healthcare

Access to resources Recommend Favorite

Potential Targets for Intervention in Radiation-Induced Heart Disease

By  

Current Drug Targets, Vol. 11, Iss. 11, 2010-11 ,pp. : 1405-1412

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutics for Diabetic Micro- and Macrovascular Complications

By  

Current Medicinal Chemistry, Vol. 13, Iss. 15, 2006-06 ,pp. : 1777-1788

Bentham Science Publishers

Access to resources Recommend Favorite